Literature DB >> 35815421

Digital Staging of Hepatic Hemangiomas Reveals Spatial Heterogeneity in Endothelial Cell Composition and Vascular Senescence.

Stefan Thomann1,2, Marcell Tóth1, Simon David Sprengel3, Jakob Liermann3, Peter Schirmacher1.   

Abstract

Hepatic hemangioma (HH) is the most common benign primary liver tumor; however, despite its high prevalence, a stage-specific classification of this tumor is currently missing. For a spatial stage-specific classification, a tissue microarray (TMA) consisting of 98 HHs and 80 hemangioma margins and 78 distant liver tissues was digitally analyzed for the expression of 16 functional and vascular niche-specific markers. For cross-correlation of histopathology and functional characteristics, computed tomography/MRI imaging data of 28 patients were analyzed. Functional and morphological analyses revealed a high level of intra- and interpatient heterogeneity, and morphological heterogeneity was observed with regard to cellularity, vascular diameter, and endothelial cell subtype composition. While regressed hemangiomas were characterized by low blood vessel density, low beta-catenin levels, and a microvascular phenotype, non-regressed HHs showed a pronounced cellular and architectural heterogeneity. Functionally, cellular senescence-associated p16 expression identified an HH subgroup with high vascular density and increased lymphatic endothelial cell content. Histological HH regions may be grouped into spatially defined morphological compartments that may reflect the current region-specific disease stage. The stage-specific classification of HHs with signs of regression and vascular senescence may allow a better disease course-based and cell state-based subtyping of these benign vascular lesions.

Entities:  

Keywords:  continuous endothelial cells; endothelial cell heterogeneity; lymphatic endothelial cells; vascular senescence; vascular tumors

Mesh:

Substances:

Year:  2022        PMID: 35815421      PMCID: PMC9284234          DOI: 10.1369/00221554221112701

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   4.137


  35 in total

1.  M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.

Authors:  Keith Q Wu; Christopher S Muratore; Eui-Young So; Changqi Sun; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

Review 2.  Vascular endothelial senescence: from mechanisms to pathophysiology.

Authors:  Jorge D Erusalimsky
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

Review 3.  The "light bulb sign" in liver hemangioma.

Authors:  Giuseppe Mamone; Roberto Miraglia
Journal:  Abdom Radiol (NY)       Date:  2019-06

4.  Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional study.

Authors:  Federico Mocchegiani; Paolo Vincenzi; Martina Coletta; Andrea Agostini; Marco Marzioni; Gianluca Svegliati Baroni; Andrea Giovagnoni; Mario Guerrieri; Cristina Marmorale; Andrea Risaliti; Marco Vivarelli
Journal:  Dig Liver Dis       Date:  2015-10-03       Impact factor: 4.088

Review 5.  Senescence and aging: the critical roles of p53.

Authors:  A Rufini; P Tucci; I Celardo; G Melino
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

Review 6.  Hepatic haemangioma: common and uncommon imaging features.

Authors:  T Klotz; P-F Montoriol; D Da Ines; V Petitcolin; J Joubert-Zakeyh; J-M Garcier
Journal:  Diagn Interv Imaging       Date:  2013-06-21       Impact factor: 4.026

7.  YAP-induced Ccl2 expression is associated with a switch in hepatic macrophage identity and vascular remodelling in liver cancer.

Authors:  Stefan Thomann; Sofia M E Weiler; Teng Wei; Carsten Sticht; Carolina De La Torre; Marcell Tóth; Fabian Rose; Yingyue Tang; Thomas Ritz; Claudia Ball; Hanno Glimm; Eduard Ryschich; Peter Schirmacher; Kai Breuhahn
Journal:  Liver Int       Date:  2021-09-27       Impact factor: 5.828

8.  Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.

Authors:  Dipti Mahajan; Charles Miller; Kenzo Hirose; Arthur McCullough; Lisa Yerian
Journal:  J Hepatol       Date:  2008-08-21       Impact factor: 25.083

9.  YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.

Authors:  Stefan Thomann; Sofia M E Weiler; Simone Marquard; Fabian Rose; Claudia R Ball; Marcell Tóth; Teng Wei; Carsten Sticht; Sarah Fritzsche; Stephanie Roessler; Carolina De La Torre; Eduard Ryschich; Olga Ermakova; Carolin Mogler; Daniel Kazdal; Norbert Gretz; Hanno Glimm; Eugen Rempel; Peter Schirmacher; Kai Breuhahn
Journal:  Cancer Res       Date:  2020-10-21       Impact factor: 12.701

10.  Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow.

Authors:  Stefan Thomann; Sunhwa Baek; Eduard Ryschich
Journal:  Oncotarget       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.